Braskem SA ADR (BAK)

Total Costs & Expenses

R$17.71B

Quarterly · Period ending: · BRL

BAK logo

BAK Total Costs & Expenses

Latest reportedR$17.71B BRL
BAK Quarterly Total Costs & Expenses · BRL (R$261.77M → R$17.71B)
High-resolution chart · PNG

BAK total costs & expenses history

Quarterly · BRL. Dates are reporting period ends; fiscal years can differ from calendar years.

Braskem SA ADR Total Costs & Expenses — Quarterly (BRL)
Period endingTotal Costs & Expenses (BRL)
17,712,000,000
15,705,000,000
15,988,000,000
18,228,000,000
18,815,000,000
19,361,000,000
19,453,000,000
20,245,000,000
19,233,000,000
17,961,000,000
17,671,000,000
17,289,000,000
19,396,000,000
18,950,000,000
18,990,000,000
24,697,000,000
23,756,000,000
22,844,759,000
22,971,495,000
21,257,573,000
17,716,279,000
15,955,000,000
17,607,000,000
16,575,000,000
12,184,000,000
12,248,000,000
14,401,108,000
12,721,646,000
12,663,000,000
11,074,077,000
13,915,000,000
13,626,519,000
11,230,660,000
11,060,090,000
9,835,289,000
9,918,140,000
9,687,945,000
9,673,473,000
9,766,000,000
9,735,914,000
9,401,231,000
9,635,793,000
10,292,000,000
10,614,545,000
9,430,199,000
9,189,328,000
10,768,000,000
10,686,654,000
10,204,088,000
10,903,291,000
10,678,000,000
9,547,782,000
8,965,647,000
8,823,617,000
8,867,000,000
9,038,750,000
8,831,888,000
8,108,253,000
8,508,235,000
8,260,069,000
7,609,617,000
6,887,681,000
6,401,840,000
6,635,197,000
5,773,215,000
3,917,659,000
5,801,200,000
2,927,000,000
2,016,000,000
2,912,788,000
2,081,532,000
6,387,680,000
4,245,306,800
4,341,771,931
4,198,969,114
4,269,390,227
3,346,842,296
2,986,053,446
1,932,546,819
3,771,566,808
3,024,533,610
2,511,470,490
3,521,046,830
3,033,425,092
2,646,682,668
3,060,063,490
3,426,768,079
2,793,819,430
3,304,326,619
2,064,387,506
2,896,024,309
2,583,984,761
1,849,906,560
2,195,982,152
2,580,229,291
2,513,801,626
493,393,997
482,162,320
1,759,357,868
462,148,201
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.